In the first half of the monitoring period, the absolute number of TMEM123+ CD8+T cells interacting with cancer cells was slightly higher than TMEM123+ CD4+ T cells (up to 1.6-fold at 24h), whereas afterwards both cell types reached a plateau with comparable numbers (Figure 6A bottom graph). This evidence concerns the gene CD4 and cancer.